The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is associated with multiple risk factors and is the most common type of dementia. Trimethylamine‐N‐oxide (TMAO), a gut microbiota metabolite derived from dietary choline and carnitine, has recently been identified as a potential risk factor of Alzheimer's disease. It has been demonstrated that TMAO is associated with Alzheimer's disease through various pathophysiological pathways. As a result of molecular crowding effects, TMAO causes the aggregation of the two proteins, amyloid‐beta peptide and tau protein. The aggregation of these proteins is the main pathology associated with Alzheimer's disease. In addition, it has been found that TMAO can activate astrocytes, and inflammatory response. Besides molecular investigation, animal and human studies have also supported the existence of a functional relationship between TMAO and cognitive decline. This article comprehensively summarizes the relationship between TMAO and Alzheimer's disease including emerging evidence from in vitro, in vivo, and clinical studies. We hope that this knowledge will improve the prevention and treatment of Alzheimer's disease in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“It is estimated that there are 44 million cases of AD globally in 2015 and the number is expected to double by 2050 (M. Prince et al., 2013).”
BackgroundDecreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Under physiological conditions, the secreted Aβ is eliminated from the brain interstitium by microglia, macrophages, and astrocytes (Frautschy et al., 1998; Mawuenyega et al., 2010; Wisniewski et al., 1991; Wyss‐Coray et al., 2003).”
BackgroundJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · cited 1×
“The aggregated Aβ binds to synaptic receptors, disturbs synapses, and activates neuroinflammation (Jarrett et al., 1993; Lomakin et al., 1997; Lue et al., 2001; Patel et al., 2005; Shankar et al., 2007; Snyder et al., 2005).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 2×
“The aggregated Aβ binds to synaptic receptors, disturbs synapses, and activates neuroinflammation (Jarrett et al., 1993; Lomakin et al., 1997; Lue et al., 2001; Patel et al., 2005; Shankar et al., 2007; Snyder et al., 2005).”
BackgroundRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“The aggregated Aβ binds to synaptic receptors, disturbs synapses, and activates neuroinflammation (Jarrett et al., 1993; Lomakin et al., 1997; Lue et al., 2001; Patel et al., 2005; Shankar et al., 2007; Snyder et al., 2005).”
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 2×
“In pathological conditions, tau dysfunction leads to tau oligomerization and fibril formation (Goedert et al., 1989; Grundke‐Iqbal et al., 1986; Ihara et al., 1986; Lee et al., 1991).”
BackgroundNormal aging induces A1-like astrocyte reactivity
Clarke, L. E., Liddelow, S. A., Chakraborty, C., Münch, A. E., Heiman, M., & Barres, B. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800165115 · Cited by 1,237
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 1×
“The pathological characteristic of the AD brain is the presence of Aβ plaques and neurofibrillary tangles (S. S. Cho et al., 2011; Glenner & Wong, 1984; Goedert et al., 1988; Masters et al., 1985).”
BackgroundBennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070 · cited 1×
“Thereafter, TMAO enters the systemic circulation via the hepatic vasculature (Bennett et al., 2013; C. E. Cho et al., 2017; Warrier et al., 2015; W. Zhu et al., 2018).”
Background
Cited by
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47
Gut microbiome and Alzheimer’s disease: What we know and what remains to be explored
Kapoor, B., Biswas, P., Gulati, M., Rani, P., & Gupta, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102570 · Cited by 46
Zhang, Y., Wang, G., Li, R., Liu, R., Yu, Z., Zhang, Z., & Wan, Z. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2022.105459 · Cited by 37
Zhou, S., Liu, J., Sun, Y., Xu, P., Liu, J. L., Sun, S., Zhu, B., & Wu, H. (2023) · Food & Function · doi:10.1039/d2fo03874a · Cited by 34
Metadata
- Authors
- Buawangpong, N., Pinyopornpanish, K., Siri‐Angkul, N., Chattipakorn, N., & Chattipakorn, S. C.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2021-11-23
- Volume
- 237
- Issue
- 3
- Pages
- 1661-1685
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W3216633157
- Cited by
- 60
- References
- 43
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease. https://app.cochat.ai/papers/10.1002/jcp.30646
- The paper
- Buawangpong, N., Pinyopornpanish, K., Siri‐Angkul, N., Chattipakorn, N., & Chattipakorn, S. C. (2022). The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.30646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.